Dai Han Pharm Co Ltd (023910)

KOSDAQ

Currency in KRW

26,400

-300(-1.12%)

Closed·02:19:28

Fair Value

Unlock Value

Day's Range

26,400

27,150

52 wk Range

24,000

31,700

023910 Income Statement

Assess the Dai Han Pharm income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 023910 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

171,462.79

184,267.55

195,911.46

204,194.88

208,614.12

Total Revenues Growth

aa.aa

+3.24%

+7.47%

+6.32%

+4.23%

+2.16%

Cost Of Revenues

aa.aa

115,780.74

124,455.11

130,599.38

134,787.58

144,169.2

Gross Profit

aa.aa

55,682.05

59,812.44

65,312.08

69,407.3

64,444.92

Gross Profit Growth

aa.aa

-0.91%

+7.42%

+9.19%

+6.27%

-7.15%

Gross Profit Margin %

aa.aa

32.47%

32.46%

33.34%

33.99%

30.89%

Other Operating Expenses, Total

aa.aa

26,614.4

26,844.39

29,516.7

31,326.79

33,259.19

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+1.46%	+0.86%	+9.95%	+6.13%	+6.17%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	790.59	567.87	1,641.15	1,802	2,206.06
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	24,780.62	25,411.34	26,956.16	28,444.63	30,038.05
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	334.4	387.26	411.75	479.63	449.95

Operating Income

aa.aa

29,067.65

32,968.05

35,795.37

38,080.51

31,185.73

Operating Income Growth

aa.aa

-2.99%

+13.42%

+8.58%

+6.38%

-18.11%

EBIT Margin %

aa.aa

16.95%

17.89%

18.27%

18.65%

14.95%

Net Interest Expenses

aa.aa

37.44

-106.77

34.71

1,473.53

1,864.04

Net Interest Expenses Growth

aa.aa

+119.1%

-385.21%

+132.51%

+4,145.08%

+26.5%

Interest Expense, Total

aa.aa

-469.27

-593.43

-52.47

-1.81

-2.69

Interest And Investment Income

aa.aa

506.7

486.66

87.18

1,475.34

1,866.73

Other Non Operating Expenses, Total

aa.aa

1,286.59

599.27

592.28

2,412.89

-201.72

EBT, Excl. Unusual Items

aa.aa

30,391.68

33,460.54

36,422.36

41,966.94

32,848.05

Gain (Loss) On Sale Of Assets

aa.aa

41.28

-9.4

22.53

58.03

31.38

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

30,432.96

33,451.15

36,733.58

42,328.56

33,153.44

EBT, Incl. Unusual Items Growth

aa.aa

+35.06%

+9.92%

+9.81%

+15.23%

-21.68%

EBT, Incl. Unusual Items Margin

aa.aa

17.75%

18.15%

18.75%

20.73%

15.89%

Income Tax Expense

aa.aa

7,762.54

8,490.6

8,307.26

8,569.46

5,509.6

Net Income to Company

aa.aa

22,670.41

24,960.55

28,426.32

33,759.1

27,643.84

Minority Interest

aa.aa

Net Income

aa.aa

22,670.41

24,960.55

28,426.32

33,759.1

27,643.84

Net Income Growth

aa.aa

+30.43%

+10.1%

+13.88%

+18.76%

-18.11%

Net Income Margin %

aa.aa

13.22%

13.55%

14.51%

16.53%

13.25%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

22,670.41

24,960.55

28,426.32

33,759.1

27,643.84

Basic EPS - Continuing Operations

aa.aa

3,778.4

4,170.67

4,834.41

5,741.34

4,701.33

Basic EPS - Continuing Operations Growth

aa.aa

+30.43%

+10.38%

+15.91%

+18.76%

-18.11%

Diluted EPS - Continuing Operations

aa.aa

3,778.4

4,170.67

4,834.41

5,741.34

4,701.33

Diluted EPS - Continuing Operations Growth

aa.aa

+30.43%

+10.38%

+15.91%

+18.76%

-18.11%

Basic Weighted Average Shares Outstanding

aa.aa

5.98

5.88

Diluted Weighted Average Shares Outstanding

aa.aa

5.98

5.88

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

40,478.83

42,175.75

44,458.71

45,362.05

40,406.44

EBITDA Growth

aa.aa

-1.9%

+4.19%

+5.41%

+2.03%

-10.92%

EBITDA Margin %

aa.aa

23.61%

22.89%

22.69%

22.22%

19.37%

EBIT

aa.aa

29,067.65

32,968.05

35,795.37

38,080.51

31,185.73

* In Millions of KRW (except for per share items)

FAQ

What was Dai Han Pharm’s revenue at year end?

At the end of the last reported fiscal year, Dai Han Pharm (023910) recorded total revenue of 208,614 million KRW.

How much revenue did Dai Han Pharm report in the most recent quarter?

In its most recent quarterly earnings report, Dai Han Pharm posted revenue of 52,715 million KRW.

What was Dai Han Pharm’s net income for the year?

For the full year, Dai Han Pharm reported net income of 27,644 million KRW.

How much net income did Dai Han Pharm post in the last quarter?

In the most recent quarter, Dai Han Pharm (023910) posted net income of 6,981 million KRW.

What was Dai Han Pharm’s gross profit for the year?

Gross profit for the year was reported at 64,445 million KRW.

How much gross profit did Dai Han Pharm generate last quarter?

Dai Han Pharm recorded gross profit of 15,754 million KRW in its latest quarterly report.

What was Dai Han Pharm’s annual operating income?

For the full year, Dai Han Pharm (023910) reported operating income of 31,186 million KRW.

What was Dai Han Pharm’s operating income last quarter?

Quarterly operating income was 7,861 million KRW.

What was Dai Han Pharm’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 10,965 million KRW.

What was the quarter-over-quarter change in EBITDA for Dai Han Pharm?

EBITDA changed by 69% million KRW compared to the last quarter.

What is Dai Han Pharm’s most recent gross profit margin?

The latest reported gross profit margin for Dai Han Pharm (023910) is 30% million KRW.

What is Dai Han Pharm’s most recent net income margin?

Net income margin based on recent financials is 13% million KRW.

What is Dai Han Pharm’s most recent EBIT margin?

Dai Han Pharm reported an EBIT margin of 15% million KRW based on current figures.

How did Dai Han Pharm’s revenue change compared to the previous quarter?

Revenue changed by 3% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Dai Han Pharm?

In the latest quarter, gross profit changed by 22% million KRW from the previous quarter.

S&P/TSX

36,667.92

-62.35

-0.17%

S&P/TSX 60

2,158.13

-6.10

-0.28%

US 30

53,422.10

-37.9

-0.07%

US 500

7,717.50

-27.9

-0.36%

S&P 500 VIX

15.19

+0.94

+6.60%

DAX

26,338.61

-101.70

-0.38%

Dollar Index

99.578

+0.044

+0.04%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	68.38	+2.97%	12.69M
RBC	300.09	-0.20%	2.23M
Enbridge	70.22	-0.55%	8.95M
Canadian Imperial Bank	171.36	-0.23%	2.89M
Shopify Inc	206.40	-3.71%	2.00M
Magna Intl	98.98	+1.46%	3.81M
Bank of Montreal	257.05	-0.32%	1.31M

Name	Last	Chg. %	Vol.
Asep Medical Holdings	0.39	+618.18%	3.00K
Asep Medical Holdings	0.39	+609.09%	3.00K
Metaguestai	0.03	+200.00%	93.75K
Metaguestai	0.03	+200.00%	93.75K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K
Psyched Wellness	0.01	+100.00%	7.50K

Name	Last	Chg. %	Vol.
Beckett’s	0.01	-100.00%	131.80K
Lanebury Growth Capital	0.05	-68.75%	18.17K
Iemr Resources	0.0050	-66.67%	2.00K
Evocati Capital Resources	0.03	-57.14%	1.00K
Nobel29 Resources	0.02	-50.00%	319.00K
Abacus Mining	0.02	-50.00%	23.86K
Martello Tech	0.0050	-50.00%	40.73K

Trending Stocks

Name	Last	Chg. %	Vol.
HIVE Digital Tech	4.2400	+13.98%	7.01M
Keel Infra	5.24	+7.60%	4.82M
Cenovus Energy Inc	44.56	+3.36%	4.34M
Canadian Natural	68.38	+2.97%	12.69M
Hut 8	122.010	+2.88%	293.89K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaa Aaaaa	127.83	+52.56%	195.02
Aaaaaaaaaaaa	1.5000	+50.18%	2.2527
A Aaaa Aaaa Aaaaaa	100.53	+47.84%	148.62
Aa Aaaaaaaa Aaaaaa	9.11	+47.04%	13.40
A Aaaaa	16.57	+46.90%	24.34
Aaaaaa Aaaaaaaa Aa	30.49	+44.77%	44.14
Aa Aaa Aaaaaaaaaa	33.23	+43.85%	47.80

Name	Last	Upside	Fair Value
Aaaaaaaaaaaa Aaaaa	127.83	+52.56%	195.02
Aaaaaaaaaaaa	1.5000	+50.18%	2.2527
A Aaaa Aaaa Aaaaaa	100.53	+47.84%	148.62
Aa Aaaaaaaa Aaaaaa	9.11	+47.04%	13.40
A Aaaaa	16.57	+46.90%	24.34
Aaaaaa Aaaaaaaa Aa	30.49	+44.77%	44.14
Aa Aaa Aaaaaaaaaa	33.23	+43.85%	47.80

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Dai Han Pharm Co Ltd (023910)

023910 Income Statement

FAQ

What was Dai Han Pharm’s revenue at year end?

How much revenue did Dai Han Pharm report in the most recent quarter?

What was Dai Han Pharm’s net income for the year?

How much net income did Dai Han Pharm post in the last quarter?

What was Dai Han Pharm’s gross profit for the year?

How much gross profit did Dai Han Pharm generate last quarter?

What was Dai Han Pharm’s annual operating income?

What was Dai Han Pharm’s operating income last quarter?

What was Dai Han Pharm’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Dai Han Pharm?

What is Dai Han Pharm’s most recent gross profit margin?

What is Dai Han Pharm’s most recent net income margin?

What is Dai Han Pharm’s most recent EBIT margin?

How did Dai Han Pharm’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Dai Han Pharm?

Trending Stocks